Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)

Hong Kong · Delayed Price · Currency is HKD

449.20

+2.00 (0.45%)

At close: May 11, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Pharmaceuticals	2.06B	1.93B	1.54B	803.93M	32.32M
Pharmaceuticals Growth	6.46%	25.48%	91.62%	2387.26%	-
Total	2.06B	1.93B	1.54B	803.93M	32.32M
Total Growth	6.46%	25.48%	91.62%	2387.26%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
The PRC	571.20M	92.65M	7.54M	56.49M	20.39M
The PRC Growth	516.48%	1128.18%	-86.64%	177.11%	-
The United States of America	1.31B	1.84B	1.53B	730.04M	-
The United States of America Growth	-28.56%	20.43%	109.33%	-	-
Switzerland	168.69M	-	-	-	-
Other Countries	3.31M	-	4.73M	17.41M	11.94M
Other Countries Growth	-	-	-72.85%	45.83%	-
Total	2.06B	1.93B	1.54B	803.93M	32.32M
Total Growth	6.46%	25.48%	91.62%	2387.26%	-

Source: S&P Global Market Intelligence.